Company / SG&A Expense
Mind Medicine (MindMed) Inc. SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$48.6M
FY2025
5-year range
$30.2M / $59.1M
FY2021-FY2025
Trend
+26.0%
vs FY2024
Sector context
#162 of 213
Health Care
What the data says
Mind Medicine (MindMed) Inc.'s sg&a expense of $49M is lower than 76% of companies in the Health Care sector (FY2025). SG&A Expense has fluctuated over the past 7 years, ranging from $3M in FY2019 to $59M in FY2021.
Based on SEC 10-K filings.
$49M in FY2025 with a 5-year CAGR of +27.6%.
Increased from $42M to $49M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +17.3%
- 5-Year CAGR
- +27.6%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 213This company $48.6M Sector average $722.3M
▼
-93.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +27.6%, indicating consistent growth.
- In FY2025, sg&a expense increased 26.0% year-over-year.
- Ranks #162 out of 213 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.70 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $48.6M | +26.0% |
| FY2024 | $38.6M | -7.5% |
| FY2023 | $41.7M | +38.4% |
| FY2022 | $30.2M | -48.9% |
| FY2021 | $59.1M | +310.2% |
| FY2020 | $14.4M | +353.1% |
| FY2019 | $3.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026